1.
Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy
for the diagnosis, management, and prevention of chronic obstructive pulmonary disease:
GOLD executive summary. Am J Respir Crit Care Med. 2013; 187 (4): 347-65.
2.
Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL Held LS, et al. Chronic obstructive
pulmonary disease: current burden and future projections. Eur Respir J. 2006; 27 (2):
397-412.
3.
World Health Organization. The global burden of disease: 2004 update. Geneva, Switzerland:
World Health Organization; 2008. 146 p.
4.
Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E, Sanchez G, et
al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and
daily life activities. Thorax. 2009 Oct;64(10):863–8.
5.
Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, et al. Managing
dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian
Thoracic Society clinical practice guideline. Can Respir J. 2011 Apr;18(2):69–78.
6.
Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbation. Chest. 2000;117
(5 Suppl 2): 398S-401S. 7. Miravitlles M, García-C Polo, Domenech A, G Villegas, Conget
F, the Roza C. Clinical outcomes and cost analysis in exacerbation of chronic obstructive
pulmonary disease. Lung. 2013; 191 (5): 523-30.
8.
JL López-Campos, Hartl S Pozo-Rodriguez F, CM Roberts, European COPD Audit team. European
COPD Audit: design, Organisation of work and methodology. Eur Respir J. 2013; 41(2):
270-6.
9.
Miravitlles M Soler-Cataluña JJ, Calle F, J Molina, Almagro P Quintano JA, et al.
Guide Spanish COPD (GesEPOC). Update 2014. Arch Bronconeumol. 2014; 50 (Suppl 1):
1-16.
10.
Xu S, Wang L, Cooper E, Zhang M, Manheimer E, Berman B, et al. Adverse events of acupuncture:
a systematic review of case reports. Based Complement Altern Med-evident ECAM. 2013;
2013: 581203.
11.
Alice J Lau KSL and YM. A single session of Acu-TENS increasi you reduce dyspnoea
and FEV1 in Patients with chronic obstructive pulmonary disease: a randomised, placebo-controlled
trial. 2008; 54 (3): 179-84.
12.
AYM Jones and Shirley N PC and Hui-Chan, Christina WY and Yu, Homer PM. Acute Effects
of Acu-TENS on FEV1 and Blood Β-Endorphin Level in Chronic Obstructive Pulmonary Disease.
2011; 17 (5): 8-13.
13.
Ngai SPC and Alice J YM and Hui-Chan, Christina WY and Ko, Fanny and WS Hui, David
SC. Effect of 4 weeks of Acu-TENS on functional capacity and beta-Endorphin level
in subjects with chronic obstructive pulmonary disease: a randomized controlled trial.
January 1, 2010; 173(1): 29-36.
14.
SPC Ngai, AYM Jones, Hui-Chan CWY, FWS Ko Hui DSC. An adjunct intervention for management
of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). J Altern
Complement Med NY N. 2013; 19 (2): 178-81.
15.
Kelly AM. The minimum clinically significant difference in visual analogue pain scale
score does not Differ with severity of pain. EMERG Med J. 2001; 18 (3): 205-7.
16.
Kendrick KR, Baxi SC, Smith RM. Usefulness of the modified 0-10 Borg scale in assessing
the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs. 2000 Jun;26(3):216–22.